Dec 2011

Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness

Antimicrob Agents Chemother

by Kaiser M, Bray MA, Cal M, Bourdin Trunz B, Torreele E, and Brun R. Antimicrob Agents Chemother, Dec 2011, 55(12):5602-8. doi: 10.1128/AAC.00246-11. Epub 2011 Sep 12.

Click here to read the article

Latest scientific articles

Stay connected

Get our latest news, personal stories, research articles, and job opportunities.

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness

Latest scientific articles

Development and validation of ultra-performance liquid chromatography tandem mass spectrometry methods for the quantitative analysis of the antiparasitic drug DNDI-6148 in human plasma and various mouse biomatrices

Changes in lipid abundance are associated with disease progression and treatment response in chronic Trypanosoma cruzi infection

Climate change, migration, and health: perspectives from Latin America and the Caribbean

Immunotherapeutic strategies as potential treatment options for cutaneous leishmaniasis

Stay connected

Learn more

Get in touch

Support us

Work with us